Royalty Pharma plc

Historical 13F Holders

Symbol
RPRX
CUSIP
G7709Q104
All holders as of
Q3 2024
Type
Equity
Class
SHS CLASS A
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2024 Q4 67 19.3 M $492 M
2024 Q3 398 306 M $8.65 B
2024 Q2 388 368 M $9.70 B
2024 Q1 389 396 M $12.0 B
2023 Q4 374 369 M $10.4 B
2023 Q3 328 300 M $8.15 B
2023 Q2 336 319 M $9.31 B
2023 Q1 344 301 M $10.9 B
2022 Q4 348 307 M $12.1 B
2022 Q3 331 301 M $12.1 B
2022 Q2 296 291 M $12.2 B
2022 Q1 294 270 M $10.5 B
2021 Q4 283 268 M $10.7 B
2021 Q3 245 264 M $9.56 B
2021 Q2 252 250 M $10.2 B
2021 Q1 230 247 M $15.0 B
2020 Q4 217 231 M $13.4 B
2020 Q3 145 159 M $8.19 B
2020 Q2 127 150 M $8.96 B
2020 Q1 1 15.0 $1.00 k
2019 Q4 1 15.0 $1.00 k
2019 Q3 1 15.0 $1.00 k
2019 Q2 1 15.0 $1.00 k
2019 Q1 1 15.0 $1.00 k